Despite its rarity, it is crucial for physicians to remain vigilant regarding the signs and symptoms of this condition, particularly given its potential association with commonly prescribed medications for highly prevalent diseases - such as type 2 diabetes mellitus - and oral antidiabetic agents like DPP-4 inhibitors, whose link to BP is well established. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.